Papers - SAKURABA Hirotake
-
Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial
9. Nakase H, Motoya S, Matsumoto T et al
Aliment Pharmacol Ther 2017.9
-
Successful adalimumab treatment and usefulness of capsule endoscopy for gut inflammation concomitant with ankylosing spondylitis
Shinji Ota, Hirotake Sakuraba, Hiroto Hiraga, Keisuke Hasui, Miwa Satake,Norihiro Hanabata, Yui Akemoto, Rina Watanabe, Nahoko Tanaka, Yoh Ishiguro, Masanori Tanaka, Shinsaku Fukuda
Mod Rheumatol 2017.2
-
早期胃癌に対する内視鏡的粘膜下層剥離術の周術期におけるエネルギー代謝の検討
珍田大輔、速水史郎、柳町幸、塚本利昭、新井徹、宮澤邦昭、菊池英純、平賀寛人、澤谷学、櫻庭裕丈、三上達也、下山克、福田眞作
消化と吸収 2016.9
-
Capsule Endoscopy for Differentiating Early Crohn's Disease from Behçet's
Miwa Satake, Hirotake Sakuraba, Hiroto Hiraga, Norihiro Hanabata, Noriko Hiraga, Keisuke Hasui, Shinji Ota, Yui Akemoto, Tatsuya Mikami, Yoh Ishiguro, Shinsaku Fukuda
Journal of Inflammatory Bowel Disease 2016.6
-
Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group.
Hirabayashi Y, Munakata Y, Miyata M, Urata Y, Saito K, Okuno H, Yoshida M, Kodera T, Watanabe R, Miyamoto S, Ishii T, Nakazawa S, Takemori H, Ando T, Kanno T, Komagamine M, Kato I, Takahashi Y, Komatsuda A, Endo K, Murai C, Takakubo Y, Miura T, Sato Y, Ichikawa K, Konta T, Chiba N, Muryoi T, Kobayashi H, Fujii H, Sekiguchi Y, Hatakeyama A, Ogura K, Sakuraba H, Asano T, Kanazawa H, Suzuki E, Takasaki S, Asakura K, Sugisaki K, Suzuki Y, Takagi M, Nakayama T, Watanabe H, Miura K, Mori Y; Michinoku Tocilizumab Study Group.
Mod Rheumatol ( 2 ) 1 - 35 2016.3
-
Prediction of maintained mucosal healing in patients with Crohn's disease under treatment with infliximab using diffusion-weighted magnetic resonance imaging.
Hirotake Sakuraba, Yoh Ishiguro, Keisuke Hasui, Hiroto Hiraga, Shinsaku Fukuda, Koichi Shibutani, Yoshihiro Takai
Digestion 89 ( 1 ) 49 - 54 2014.1
-
Cyclosporine protects from apoptosis-mediated epithelial damage through epithelial STAT3 signaling pathway in DSS-induced colitis
Hirotake Sakuraba, Yoh Ishiguro, Hiroto Hiraga, Keisuke Hasui, Shinsaku Fukuda
Inflammatory Bowel Disease Suppl19 ( 13 ) S103 - S104 2013.12
-
大動脈縮窄症術語２５年目に発症した人工血管十二指腸ろうの１例
岡田有史他
日本消化器病学会雑誌 109 2049 - 2057 2012.5
-
[Characteristic future of intestinal Behçet's disease and simple ulcer].
Kazufumi Yamagata, Hirotake Sakuraba, Shinsaku Fukuda, Yoh Ishiguro, Masanori Tanaka
Nihon rinsho. Japanese journal of clinical medicine 70 Suppl 1 573 - 580 2012.2
-
[Natural history and disease progression of Crohn's disease].
Yoh Ishiguro, Keisuke Hasui, Hirotake Sakuraba, Kazufumi Yamagata, Shinsaku Fukuda, Avako Ishiguiro
Nihon rinsho. Japanese journal of clinical medicine 70 Suppl 1 153 - 158 2012.2
-
Interferon-a2b induced p21cipI/wafl degradation and cell proliferation in HeLa cells.
Ken Ota, Tomoh Matsumiya, Hirotake Sakuraba, Tadaatsu Imaizumi, Hidemi Yoshida, Shogo Kawaguchi, Shinsaku Fukuda and Kei Satoh
Cell Cycle 1 1 - 9 2010.1
-
Cyclosporine Regulates Intestinal Epithelial Apoptosis via TGF-beta Related Signaling.
Satoh Y, Ishiguro Y, Sakuraba H, Kawaguchi S, Hiraga H, Fukuda S, Nakane A.
Am J Physiol Gastrointest Liver Physiol 2009.7
-
Retinoic acid-inducible gene-I is constitutively expressed and involved in IFN-gamma-stimulated CXCL9-11 production in intestinal epithelial cells.
Kawaguchi S, Ishiguro Y, Imaizumi T, Mori F, Matsumiya T, Yoshida H, Ota K, Sakuraba H, Yamagata K, Sato Y, Tanji K, Haga T, Wakabayashi K, Fukuda S, Satoh K.
Immunology Letter 23 ( 123 ) 9 - 13 2009.2
-
Blockade of TGF-beta accelerates mucosal destruction through epithelial cell apoptosis.
Sakuraba H, Ishiguro Y, Yamagata K, Munakata A, Nakane A.
Biochem Biophys Res Commun 359 ( 3 ) 406 - 412 2007.8
-
The role of macrophage migration inhibitory factor in lethal Listeria monocytogenes infection in mice.
3. Sashinami H, Sakuraba H, Ishiguro Y, Munakata A, Nishihira J, Nakane A.
Micro Pathog 41 ( 2 ) 111 - 118 2006.12
-
Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil and systemic irinotecan in patients with unresectable liver metastases from colorectal cancer.
Shitara K, Munakata M, Kudo T, Kasai M, Muto O, Okada R, Mitobe S, Ishiguro A, Sakuraba H, Ikami I, Sakata Y
Gan To Kagaku Ryoho 33 ( 13 ) 2033 - 2037 2006.12
-
Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis.
4. Ishiguro Y, Ohkawara T, Sakuraba H, Yamagata K, Hiraga H, Yamaguchi S, Fukuda S, Munakata A, Nakane A,
Clin Immunol. 120 ( 3 ) 335 - 341 2006.11
-
The presentation of haptenated proteins and activation of T cells in the mesenteric lymphnodes by dendritic cells in the TNBS colitis rat.
Ishiguro Y, Yamagata K, Sakuraba H, Munakata A,
Ann N Y Acad Sci. 1029 346 - 347 2004.4
-
Macrophage migration inhibitory factor and activator protein-1 in ulcerative colitis.
Ishiguro Y, Yamagata K, Sakuraba H, Nakane A, Munakata A
Ann N Y Acad Sci. 1029 348 - 349 2004.4
-
Transforming growth factor-beta regulates susceptibility of epithelial apoptosis in murine model ofcolitis
5. Sakuraba H, Ishiguro Y, Yamagata K, Tagawa Y, Iwakura Y, Sekikawa K, Munakata A, Nakane A.
Ann N Y Acad Sci 1029 382 - 384 2004.4